Increasing trend of acute hepatitis A in north India: Need for identification of high-risk population for vaccination

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 4, 2006, Pages 689-693

  Hussain, Zahid ^a,b   Das, Bhudev C ^c   Husain, Syed A ^b   Murthy, Nandagudi S ^d   Kar, Premashis ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^c INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

^d INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Acute viral hepatitis; Epidemiological shift; Hepatitis A; IgG anti HAV; Immunity; Vaccination

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HEPATITIS E ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ALCOHOL LIVER CIRRHOSIS; ANALYTIC METHOD; ANTIBODY DETECTION; ARTICLE; CHILD; CHRONIC LIVER DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEPATITIS A; HEPATITIS B; HIGH RISK POPULATION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; VACCINATION; VIRUS HEPATITIS;

EID: 33645840147     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04232.x     Document Type: Article

References (41)

1. Cuthbert JA. Hepatitis A: old and new. Clin. Microbiol. Rev. 2001 14 38 58.
2. Lednar WM Lemon SM Kirkpatrick JW Redfield RR Fields ML Kelly PW. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am. J. Epidemiol. 1985 122 226 33.
3. Cotton MG Locarnini SA. Hepatitis A virus epidemiology. In Zuckermann AJ Thomas HC eds. Viral Hepatitis. London Churchill Livingstone 1998 29 41.
4. Wilner IR Uhl MD Howard SC Williams EQ Riely CA Waters B. Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States. Ann. Intern. Med. 1998 128 111 14.
5. Bell BP Shapiro CN Alter MJ et al. The diverse patterns of hepatitis A epidemiology in the United States: implications for vaccination strategies. J. Infect. Dis. 1998 178 1579 84.
6. Craig AS Schaffner W. Prevention of hepatitis A with the hepatitis A vaccine. N. Engl. J. Med. 2004 350 476 81.
7. Xu ZY Li ZH Wang JX Xiao ZP Dong DX. Etiology and prevention of a shellfish-associated epidemic in Shanghai, China. Vaccine 1992 10 Suppl. S67 8.
8. Hutin YJF Pool V Cramer EH et al. A multistate, foodborne outbreak of hepatitis A. N. Engl. J. Med. 1999 340 595 602.
9. Rakela J Redeker AG Edwards VM Decker R Overby LR Mosley JW. Hepatitis A virus infection in fulminant hepatitis and chronic active hepatitis. Gastroenterology 1978 74 879 82.
10. Barzaga BN. Hepatitis A: shifting epidemiology in South East Asia and in China. Vaccine 2000 18 Suppl. 1 S61 4.
11. Poovorawan Y Theamboonlers A Sinlaparatsamee S et al. Increasing susceptibility to HAV among members of the young generation in Thailand. Asian Pac. J. Allergy Immunol. 2000 18 249 53.
12. Tanaka J. Hepatitis A shifting epidemiology in Latin America. Vaccine 2000 18 Suppl. 1 S57 60.
13. Sohn YM Rho HO Park MS. The changing epidemiology of hepatitis A in children and the consideration of active immunization in Korea. Yonsei. Med. J. 2000 41 34 9.
14. Dal-Re R Garcia-de-Lomas J. A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A. J. Med. Virol. 2000 60 363 6.
15. Gdalvich M Grotto I Mandel Y Mimouni D Sherman J Ashkenizi I. Hepatitis A antibody prevalence among young adults in Israel: the decline continues. Epidemiol. Infect. 1998 1221 477 9.
16. Lee SD. Asian perspectives on viral hepatitis A. J. Gastroenterol. Hepatol. 2000 15 Suppl. G94 9.
17. Byun KS Kim JH Song KG et al. Molecular epidemiology of the hepatitis A virus in Korea. J. Gastroenterol. Hepatol. 2001 16 519 24.
18. Tandon BN Gandhi BM Joshi YK Irshad M Gupta H. Hepatitis virus non-A, non-B: The cause of a major public problem in India. Bull. World Health Organ. 1985 63 931 4.
19. Das K Jain A Gupta S et al. The changing epidemiological pattern of hepatitis A virus in an urban population in India: emergence of a trend similar to European countries. Eur. J. Epidemiol. 2000 16 507 10.
20. Dhawan PS Shah SS Alvares JF et al. Seroprevalence of hepatitis A in Mumbai and immunogenicity and safety of hepatitis A vaccine. Indian. J. Gastroenterol. 1998 17 16 18.
21. Mall ML Rai RR Philip M et al. Seroepidemiology of hepatitis a in India: Changing pattern. Indian. J. Gastroenterol. 2001 20 130 2.
22. Perez TE Cilla G Urbieta M Dorronsono M Otero F Mazrimon JM. Falling incidence and prevalence of hepatitis A in Northern Spain. Scand. J. Infect. Dis. 1994 26 133 6.
23. Perez TE Cilla EG Urbieta M Garcia BM. Prevalence of hepatitis A in Spain. Scand. J. Infect. Dis. 1988 20 113.
24. Kremastinou T Kalapothaki V Trichopoulos D. The changing epidemiologic pattern of hepatitis A infection in urban Greece. Am. J. Epidemiol. 1986 120 703 6.
25. Mele A Pasquini P Pana A. Hepatitis A in Italy: epidemiology and suggestions for control. Ital. J. Gastroenterol. 1991 23 341 3.
26. Chairamonte M Moschen M Stroffolini T Renzulli G. Changing epidemiology of Hepatitis A virus (HAV) infection: a comparative seroepidemiology study (1979 vs 1989) in northeast Italy. Ital. J. Gastroenterol. 1991 23 344 6.
27. Frosner G Willers H Muller R et al. Decrease in incidence of hepatitis A in Germany. Infection 1978 6 259 60.
28. Marino RT Valente AR Ramatho FJ de Moura MC. The changing epidemiological pattern of hepatitis A in Lisbon, Portugal. Eur. J. Gastroenterol. Hepatol. 1997 9 795 7.
29. Beutels M van Damme P Vranckx R Meheus A. The shift in prevalence of hepatitis A immunity in Flanders, Belgium. Acta Gastroenterol. Belg. 1998 LX1 4 7.
30. Buma AH Beutels P van Damme P et al. An economic evaluation of hepatitis a vaccination in Dutch military personnel. Mil. Med. 1998 163 564 7.
31. Weiland O Berg JUR Bottiger M Lundbergh P. Prevalence of antibody against hepatitis A in Sweden in relation to age and type of community. Scand. J. Infect. Dis. 1980 12 171 43.
32. Frosner GG Papaevanglous G Butter R et al. Antibody against hepatitis A in seven European countries. Comparison of prevalence in different age groups. Am. J. Epidemiol. 1979 110 63 9.
33. Forbes A William R. Increasing age: an important adverse prognostic factor in hepatitis A virus infection. J. R. Coll. Physicians Lond. 1988 22 237 9.
34. Lemon SM Shapiro CN. The value of immunization against hepatitis A. Infect. Agents Dis. 1994 3 38 49.
35. Smeldie A Farci P Verma G et al. Inference of delta infection on severity of hepatitis B. Lancet 1982 2 945 7.
36. Ishak K Babtista A Bianchi L. Histological grading and staging of chronic hepatitis. J. Hepatol. 1995 22 696 9.
37. Arankalle VA Tsarev SA Chadha MS et al. Age specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982. J. Infect. Dis. 1995 171 447 50.
38. Das K Kar P Gupta RK et al. Are chronic liver disease patients at greater risk of hepatitis A superinfection? J. Gastroenterol. Hepatol. 2001 16 Suppl. A53.
39. Batra Y Bhattal B Kaur K Saraya A Panda SK Acharya SK. Vaccination against hepatitis A virus may not be required for school children in northern India: Results of a seroepidemiological survey. Bull. World Health Organ. 2002 80 728 31.
40. Vento S Garafano T Rezini C et al. Fulminant hepatitis associated with hepatitis A superinfection in patients with chronic hepatitis C. N. Engl. J. Med. 1998 338 286 90.
41. Green MS Tsur S Slepon R. Sociodemographic factors and the declining prevalence of anti-hepatitis A antibodies in young adults in Israel: Implications for the new hepatitis A vaccine. Int. J. Epidemiol. 1992 21 136 41.